Skip to main content

Ostomy Care Accessories Market | Coloplast (Denmark) and Hollister Incorporated (US) are the Key Players

The global ostomy care accessories market is estimated to be valued at USD 2.40 Billion in 2017 and is projected to reach USD 2.99 Billion by 2022, growing at a CAGR of 4.5%. The high incidence of bladder/colorectal cancer/inflammatory bowel disease; rising geriatric population; growing number of awareness programs to educate patients regarding the use of ostomy products; technological advancements in ostomy products; and efficient reimbursement system in developed countries are factors driving the growth of the ostomy care market.

Analysis of the ostomy care accessories market developments between 2015 and 2017 revealed that several growth strategies such as product launches and product enhancements, strategic acquisitions, agreements, contracts, and market expansions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the ostomy care market. Among these business strategies, product launches and product enhancements were the most widely adopted growth strategies by players to strengthen their product portfolios.

Coloplast (Denmark) is a leader in the ostomy care accessories market. The company’s growth in the ostomy care market is supported by a strong pipeline of new products, sustained cost discipline, and adoption of new strategies to enhance the product portfolio based on new technologies available in the market. The ostomy care business of the company has grown by 9% in 2015–16, which was almost the double of the overall market growth rate. This growth was mainly supported by the launch of its SenSura Mio. Emerging markets of China, India, and Russia are expected to offer lucrative growth opportunities for the growth of the company.

Hollister Incorporated (US) held the second position in the ostomy care accessories market in 2016. Hollister has built its position through internal development, in-licensing of technologies, product enhancements, and new product launches. The company also upgrades several products at regular intervals, which helps in retaining its customer base and addressing patient needs.

Labels:

Comments

Post a Comment

Popular posts from this blog

Best Accounting Software to Kick-start the Business for Smaller Firms – Xero

  Xero Accounting Software is an online software mainly designed for the accounting needs of small business firms. The software can be operated from a PC, phone, tablet, or Mac to view the cash flows of the company in real-time. The software is for small business houses and hence it is simple to use yet smart so that the users can devote most of the time in other important areas of their business. USP of This Software: Xero accounting software offers accounting services to small business firms in a smarter way. Some of the USPs of the software the more than 800apps integrated into the software, secure encryption, support system better performance report generation, and others apart from the basic accounting services offered. Best Accounting Software for Medium-Sized Businesses@ https://blog.360quadrants.com/2020/best-accounting-software-for-medium-sized-businesses/ Xero Pricing Xero accounting software offers 30 days of free trial after which you can choose from any of the pri...
Post a Comment
Read more

Risk-based Monitoring Software Market | Key Factor in Clinical Trial | Market Growth Worth $511 million

  Growth in the risk based monitoring software market can primarily be attributed to factors such as the cost and time efficiency of RBM solutions, rising number of clinical trials, and increasing government funding and grants to support clinical trials. However, the high implementation cost of RBM solutions is expected to restrain the growth of this market during the forecast period. RBM Software Market Dynamics: Impact Analysis 1. Increased outsourcing of clinical trial processes to CROs 2. Cost and time efficiency of RBM solutions 3. Increasing government funding and grants to support clinical trials 4. Increased pharmaceutical R&D spending 5. Initiatives to boost digital health to propel market growth The risk-based monitoring (RBM) software market is expected to reach USD 511 million by 2025 from USD 273 million in 2020, at a CAGR of 13.3% Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=102112429 Software Component: The sof...
Post a Comment
Read more

Cell Sorting Market

The global  cell sorting market  is projected to reach USD 247.4 Million by 2021, at a CAGR of 7.0% in the forecast period (2016-2021). Factors such as technological advancements in cell sorters, rising funding and investments for development of technologically advanced cell sorters, and growing adoption of cell sorting techniques in research activities are driving the growth of global Market. The market is further driven by factors such as the growing prevalence of HIV/AIDS and cancer, expanding pharmaceutical and biotechnology industries, and launch of specific reagents for specific applications. However, factors such as the high cost of instruments and lack of awareness & technical knowledge regarding the use of cell sorters are hampering the growth of market. Geographically, the market is segmented into North America, Europe, Asia-Pacific, and RoW. Among the four geographic regions, North America is estimated to command the largest share of the market in 2016, foll...
Post a Comment
Read more